Medicine
Megestrol 40 mg tablet
Megestrol 40 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F)…
Key facts
- Active ingredient (INN)
- Megestrol
- Brand
- Sold under the generic name
- Strength
- 40 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 250 tablets, 500 tablets and 8 more
- Manufacturers
- Strides PharmaIndiaBryant Ranch PrepackMajor PharmaceuticalsTeva Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15° to 30°C (59° to 86°F). Protect from temperatures above 400C (1040F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02AB01 Megestrol
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 30 November 1995
- Identifiers
- RxCUI 860221, 860215DailyMed set ID dd6617df-0876-4fc5-8435-b53d29ccc1ae, 66573d39-f2a7-49fd-9ed2-97ac8f6e8456, 9b764cf3-4756-4f0e-b747-421d71674313 +2NDC 71335-2181, 0555-0607, 71335-2544 +2Application ANDA072423, ANDA074621
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet in 1 bottle | 64380-159-01 | Strides PharmaIndia | 4 April 2022 |
| 250 tablet in 1 bottle | 64380-159-02 | Strides PharmaIndia | 4 April 2022 |
| 500 tablet in 1 bottle | 64380-159-03 | Strides PharmaIndia | 4 April 2022 |
| 100 tablet in 1 bottle | 0555-0607-02 | Teva Pharmaceuticals | 30 November 1995 |
| 30 tablet in 1 bottle | 71335-2181-1 | Bryant Ranch Prepack | 25 October 2022 |
| 100 tablet in 1 bottle | 71335-2181-2 | Bryant Ranch Prepack | 25 October 2022 |
| 15 tablet in 1 bottle | 71335-2181-3 | Bryant Ranch Prepack | 25 October 2022 |
| 30 tablet in 1 bottle | 71335-2544-1 | Bryant Ranch Prepack | 17 January 2025 |
| 100 tablet in 1 bottle | 71335-2544-2 | Bryant Ranch Prepack | 17 January 2025 |
| 15 tablet in 1 bottle | 71335-2544-3 | Bryant Ranch Prepack | 17 January 2025 |
| 100 blister pack in 1 carton / 1 tablet in 1 blister pack | 0904-7236-61 | Major Pharmaceuticals | 1 June 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 August 1971 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Megestrol
Clinical summary
Megestrol is a progestin indicated for the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS). It is available as oral suspension and tablets. MedsAcross supplies Megestrol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MegestrolFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Megestrol Acetate prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Megestrol 40 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.